Closing Bell: Sun Pharma claimed the top winner spot on the Sensex with a gain of 1.7 per cent on launching an anti-cancer drug Palbociclib in India for patients with advanced breast cancer
Since the start of the current year, the Nifty Realty pack has remained laggard and traded with a weak bias down 1.5 cent lower so far in 2023.
Higher-than-expected capex, delayed price repair and a lack of 5G monetization should halt the industry wide ROIC repair that the brokerage firm now expects to decline/flat-line over FY23-25.
In past one week, the stock has outperformed the market by surging 25 per cent, as compared to 1.8 per cent decline in the S&P BSE Sensex.
Monnet Power Assets, once operational, will provide an opportunity for the company to improve the heat rate, resulting in lower usage of coal in the power plant, said ICICI Securities in its report.
On the broader market outlook, the technical & derivative analyst from HDFC Securities expects the near term trend on the Nifty to remain bearish as long as the index stays below 18,141.
Shares of Tata Motors surged 7 per cent in Tuesday's intra-day trade to hit a high of Rs 417.7 apiece
CLOSING BELL: Broader markets, too, bled simultaneously in trade as Nifty MidCap 100 and Nifty SmallCap 100 indices fell up to 0.5 per cent
In past 12 trading sessions, the stock has zoomed 44 per cent and now quotes at its highest level since August 2015.
Following a strong close over the 200-DMA set at Rs 2,559, the chart structure of Reliance Industries reveals a "Double Bottom" breakout
In H1FY23, Ebitda margins improved 200 bps to 14.2% on account of improved sales realisation, favourable product mix, moderation in input costs, procurement efficiencies and better operating leverage.
Moderation of attrition is a positive and indicates easing of supply side challenges, which is likely to support margins, going ahead, ICICI Securities said in its note.
According to the technical analyst from Anand Rathi, Laurus Labs can rally to Rs 400; while RateGain can jump to Rs 330.
HG Infra and PNC Infratech hit respective 52-week highs in trades so far on Monday
The company said December quarter witnessed positive momentum in footfalls and revenue across all the markets majorly driven by strong festive demand.
Closing Bell: Nifty IT fell 2 per cent followed by 0.7-1 per cent cuts each in Bank, Financial, Metal, Realty and Pharma indices. FMCG and Consumer Durables outperformed with fractional gains
The broader trend in Bajaj Finance and Bajaj Finserv stocks has turned weak and if both these stocks fail to rebound overcoming key levels, the sell-off could intensify.
In past six months, the stock has rallied 122 per cent, as against 12 per cent rise in the S&P BSE Sensex.
The board of directors of the company had fixed Friday, January 6, 2023, as the record date, for the purpose of ascertaining the eligibility of shareholders entitled for issuance of bonus shares.
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.